Cite Filings / MDGL / 0001104659-25-120744

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

MADRIGAL PHARMACEUTICALS, INC. Filed 2025-12-12 Acc 0001104659-25-120744

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2025-12-12 4 Director sold 24,800 shares at an average $552.18 ($13,694,158)
2025-12-12 4 Director sold 18,650 shares at an average $552.15 ($10,297,573)
2025-12-12 SCHEDULE 13D/A Beneficial Ownership Report
2025-12-12 SCHEDULE 13D/A Beneficial Ownership Report
2025-12-11 8-K Executive or director change
2025-12-10 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…